Siriuspoint Ltd (SPNT)

SiriusPoint Ltd (NYSE-SPNT) is a Financials-sector insurance company whose NYSE-listed security is common stock. The security_context is common equity, meaning the instrument represents an ownership interest in the company rather than a depositary receipt, fund, or debt security. SiriusPoint Ltd operates in insurance and reinsurance, with activities that span property, casualty, specialty, and other risk-transfer lines. It also provides related services tied to underwriting and claims support. This overview describes the listed common shares, not a separate pooled vehicle or fixed-income instrument, and should be read as a classification of the security rather than a description of investment merits.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-SPNT
$25.87
1.5% Upside
Fair
$28.25
10.9% Upside
Fair
Great
0.0%
November 4, 2026
6.0x
1.3x
1.0x
2.96 B
3.047 B
18.9%
87.7%
2.3
2.1%
53.7%
Valuation • Fair Value

Siriuspoint Ltd (NYSE-SPNT) Fair Value by Valuation Model

Review the available estimates for Siriuspoint Ltd (NYSE-SPNT), including Ben Graham Formula Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$25.87

Estimated upside of 1.5% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

Ben Graham Formula Value

$47.25

Classic Ben Graham valuation formula reference.

Comps Fair Value

$25.87

Comparable-company valuation reference.

Analyst Price Target

$28.25

Analysts imply upside of 10.9%.

How to read these valuation models

Use the 5 available valuation references for Siriuspoint Ltd (NYSE-SPNT) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Siriuspoint Ltd (NYSE-SPNT)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

3.001 B

Current operating scale indicator.

Revenue Forecast

3.093 B

Forward revenue estimate.

EBITDA

445.7 M

Current operating profitability reference.

EBITDA Forecast

464 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Siriuspoint Ltd (NYSE-SPNT) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Siriuspoint Ltd (NYSE-SPNT)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.29

No elevated caution signal from this screen.

Altman Z-Score

2.3

Intermediate risk zone.

FCF / Net Income

53.7%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Siriuspoint Ltd (NYSE-SPNT). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Siriuspoint Ltd (NYSE-SPNT)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 4, 2026

Days to Earnings

43

Dividend Yield

0.0%

No current dividend yield is indicated.

Payout Ratio

2.1%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Siriuspoint Ltd (NYSE-SPNT), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Siriuspoint Ltd (NYSE-SPNT) Stock Forecast & Technical Outlook

Review Siriuspoint Ltd (NYSE-SPNT) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for Siriuspoint Ltd (NYSE-SPNT) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Siriuspoint Ltd (NYSE-SPNT) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Siriuspoint Ltd (NYSE-SPNT) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Siriuspoint Ltd (NYSE-SPNT) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Siriuspoint Ltd (NYSE-SPNT) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Siriuspoint Ltd (NYSE-SPNT)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, Siriuspoint Ltd (NYSE-SPNT) has a Buy consensus, with 2 buy, 2 hold and 0 sell recommendations in the current data set.

Buy 2
Hold 2
Sell 0
FAQ Fast Investor Answers

Siriuspoint Ltd (NYSE-SPNT) Stock FAQ

Data-supported answers about Siriuspoint Ltd (NYSE-SPNT), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$25.87
Estimated upside 1.5%
Valuation Rating
Near Fair Value
Price is close to fair value
Analyst Target
$28.25
Implied upside 10.9%
Financial Health
Great
Current financial-health read

The current fair value estimate for Siriuspoint Ltd (NYSE-SPNT) is $25.87. This implies an estimated upside of 1.5% versus the current market price.

Based on the current fair value estimate, the stock is trading close to its estimated fair value.

The available analyst price target for Siriuspoint Ltd (NYSE-SPNT) is $28.25. The analyst target implies estimated upside of 10.9%.

The current financial health read for Siriuspoint Ltd (NYSE-SPNT) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Siriuspoint Ltd (NYSE-SPNT) is November 4, 2026.

The latest available data indicates no current dividend yield for Siriuspoint Ltd (NYSE-SPNT).

The current P/E ratio listed for Siriuspoint Ltd (NYSE-SPNT) is 6.0x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Siriuspoint Ltd is 2.96 B.

The current enterprise value listed for Siriuspoint Ltd is 3.047 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Siriuspoint Ltd is NYSE-SPNT, and the stock is listed on NYSE.

Siriuspoint Ltd (NYSE-SPNT) is listed on NYSE.

The current debt-to-total-capital ratio listed for Siriuspoint Ltd is 18.9%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Siriuspoint Ltd is 87.7%. Free float helps investors understand how much of the share base is available for public trading.